AST5902 trimesylate is the principal metabolite of Alflutinib (AST2818) both in vitro and in vivo. AST5902 trimesylate exerts antineoplastic activity. Alflutinib is an EGFR inhibitor [1] .
Molecular Weight:
842.88
Formula:
C30H41F3N8O11S3
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
